Showing results (341-350 of 369) with videos related to

Sort By:
Pageof 37
JCO Global Oncology|January 13, 2022
Knowledge, Practice, and Attitudes of Physicians in Low- and Middle-Income Countries on Fertility and Pregnancy-Related Issues in Young Women With Breast CancerShah Zeb Khan, Luca Arecco, Cynthia Villarreal-Garza, et al.
The Lancet. Oncology|March 2, 2025
Cancer incidence and mortality estimates in 2022 in southeast Asia: a comparative analysisEdward Christopher Dee, Mathieu Laversanne, Nirmala Bhoo-Pathy, et al.
Therapeutic Advances in Medical Oncology|June 20, 2022
Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access programOliver Illini, Hannah Fabikan, Aurélie Swalduz, et al.
Oncology|May 21, 2026
Decision making in intrathecal therapy for leptomeningeal diseaseSusanne Weindler, Thomas Hundsberger, Alfredo Addeo, et al.
Cancer Treatment Reviews|June 1, 2026
PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypesDaniele Marinelli, Fabrizio Citarella, Andrea Torchia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2025
First-line MET tyrosine kinase inhibitors versus immunotherapy ± chemotherapy for patients with MET exon 14 skipping mutant metastatic NSCLCFederica Pecci, Hui Li, Alessandro Di Federico, et al.
JCO Global Oncology|August 22, 2022
The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent ConsiderationsChristian Caglevic, Christian Rolfo, Ignacio Gil-Bazo, et al.
BMJ Oncology|January 26, 2026
Global determinants of cervical cancer outcomes: a health systems analysisAdrian Eleazar Go, Erin Jay Garbes Feliciano, Juana Martinez, et al.
Therapeutic Advances in Medical Oncology|June 28, 2021
Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access programOliver Illini, Maximilian Johannes Hochmair, Hannah Fabikan, et al.
JTO Clinical and Research Reports|March 19, 2026
Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective StudyElio Adib, Amin H Nassar, Katie N Lee, et al.
Pageof 37